Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 4Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1

Interventions

mogamulizumab 4Immunoglobulin G 3Disulfides 3Brentuximab Vedotin 3sodium-iodide symporter 2cemiplimab 2X-Rays 2Specimen Handling 2Radiotherapy 2Photons 2Magnetic Resonance Spectroscopy 2Cyclophosphamide 2Blood Specimen Collection 2Biopsy 2ruxolitinib 1hypericin 1fludarabine 1Urine Specimen Collection 1Radiation 1Positron-Emission Tomography 1Photopheresis 1Nivolumab 1Methoxsalen 1MAC-ST-001 1Ipilimumab 1Imiquimod 1Hematologic Tests 1Fenretinide 1CTLA-4 Antigen 1Bexarotene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Mycosis Fungoides × hypericin × Clear all
NCT06470451 2026-04-03

FLASH2

Soligenix

Phase 3 Recruiting
80 enrolled
DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡